REQUEST A DEMO
Total
USD $0.00
Search more companies

Pace Pharmatech Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Pace Pharmatech Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Pace Pharmatech Private Limited is based in India. The head office is in Mumbai. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on December 04, 2001. The company’s latest financial report indicates a net sales revenue increase of 30.94% in 2025. Its’ total assets recorded a growth of 14.41%. The enterprise’s net profit margin decreased by 0.3% in 2025.

Legal Address
Unit No 109 Kartik Kuber Comp. New Link Road Opp . Laxmi Industrial Estate
Mumbai; Maharashtra; Postal Code: 400053

Contact Details: Purchase the Pace Pharmatech Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Pace Pharmatech Private Limited report to view the information.
Financial Auditors:
Purchase the Pace Pharmatech Private Limited report to view the information.
Incorporation Date:
December 04, 2001
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Pace Pharmatech Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
30.94%
Total Operating Revenue
30.94%
Operating Profit
27.48%
EBITDA
29.94%
Net Profit/Loss for the Period
4.06%
Total Assets
14.41%
Total Equity
8.44%
Operating Profit Margin
-0.12%
Net Profit Margin
-0.3%
Return on Equity (ROE)
-0.38%
Debt / Equity
42.62%
Quick Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?